About
Since the completion of the Human Genome Project nearly a decade ago, continuing technological and scientific progress has brought significant advances to the fields of genomics and personalized medicine. As researchers, entrepreneurs, investors and businesses have sought to harness these advances, they have received increasing scrutiny from politicians, regulators, judges and policymakers. This, in turn, has brought a new layer of complexity to an already complicated legal and regulatory landscape.
The Genomics Law Report, a publication of the law firm Robinson, Bradshaw & Hinson, analyzes the legal implications of important developments in the fields of genomics and personalized medicine — including key litigation, legislative, regulatory and policymaking activities — to help make sense of these complex and rapidly changing areas of law and policy.
Please feel free to contact us with questions, comments or suggestions at genomicslawreport@rbh.com.
GLR Editor
 |
Dan Vorhaus advises genomics and biotechnology researchers, entrepreneurs, companies and investors on legal compliance and commercialization strategies. Full Bio |
GLR Contributors
 |
Allain Andry chairs the firm’s Life Sciences practice group and represents investors and lenders in transactions in the pharmaceutical, medical device, insurance and healthcare data fields. He also represents manufacturers of pharmaceutical, nutraceutical and nutritional products in their financing, licensing and distribution transactions. Full Bio |
 |
Bob Bryan chairs the firm’s intellectual property group and has extensive experience in acquisitions, joint ventures and licenses involving patents, trademarks and other intellectual property. Full Bio |
 |
Peter Buck practices in the areas of mergers and acquisitions and corporate and commercial law, and has extensive experience advising emerging growth companies and in in private equity and venture capital financings and buyouts. Full Bio |
 |
James Cass practices in the areas of corporate and bankruptcy law. Before joining Robinson, Bradshaw & Hinson, Cass gained experience working with Innocence Project on matters involving forensic evidence. Full Bio |
 |
John Conley is Kenan Professor of Law at the University of North Carolina and of counsel to Robinson, Bradshaw & Hinson, where he specializes in intellectual property and biotechnology. Full Bio |
 |
Danielle Conrad practices in the area of corporate and real estate law and has experience advising healthcare entities with respect to joint ventures, acquisitions and real estate matters. Full Bio |
 |
Adam Doerr represents companies and individuals involved in litigation, with an interest in the complex privacy, liability, and other legal issues arising from the field of genomics. Full Bio |
 |
Jon Ferry is a civil litigator with experience in various commercial contract disputes including intellectual property, software licensing, employment and construction disputes. Full Bio |
 |
Jeffrey Hart is co-chair of the firm’s Venture Capital and Emerging Growth Companies practice group and has substantial experience representing both investors and companies in life sciences and biotechnology investments. Full Bio |
 |
Ted Hennessey is the chair of Robinson Bradshaw’s litigation department with experience in a wide range of business litigation and arbitration matters, including employment and intellectual property disputes. Full Bio |
 |
Susan Huber practices in the areas of employment law and civil litigation, with a special interest in the ethical, legal, and social issues related to genomics. Full Bio |
 |
Jennifer Hutchens is a member of the firm’s corporate and health care practice groups. She frequently counsels clients with regard to regulatory matters, such as HIPAA and privacy issues. Full Bio |
 |
Lawrence Moore is a civil litigator with experience in intellectual property, biotechnology, and antitrust matters. Full Bio |
 |
Kate Payerle monitors regulatory and legislative developments in the field of genomics and is a litigator with an interest in intellectual property and tort matters. Full Bio |
 |
Emily Sherlock practices in the area of corporate law and has experience advising genomics and healthcare entities with respect to information privacy and disclosure laws. Full Bio |
